These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14872065)

  • 1. Introduction to The Olivieri symposium.
    Viens AM; Savulescu J
    J Med Ethics; 2004 Feb; 30(1):1-7. PubMed ID: 14872065
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry and the academy: conflicts of interest in contemporary health research.
    Downie J; Baird P; Thompson J
    Health Law J; 2002; 10():103-22. PubMed ID: 14748274
    [No Abstract]   [Full Text] [Related]  

  • 3. The Olivieri case: lessons for Australasia.
    Downie J; Thompson J; Baird P; Dodds S
    J Bioeth Inq; 2005; 2(2):90-105. PubMed ID: 16317868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
    Schafer A
    J Med Ethics; 2004 Feb; 30(1):8-24. PubMed ID: 14872066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The report of the committee of inquiry on the case involving Dr. Nancy Olivieri: a fiduciary law perspective.
    Litman M; Sheremeta L
    Health Law Rev; 2002; 10(2):3-13. PubMed ID: 15739307
    [No Abstract]   [Full Text] [Related]  

  • 6. The Olivieri Report--a compelling study of the growing tensions in clinical research.
    di Norcia V
    Sci Eng Ethics; 2003 Jan; 9(1):125-32. PubMed ID: 12645235
    [No Abstract]   [Full Text] [Related]  

  • 7. The Olivieri debacle: where were the heroes of bioethics?
    Baylis F
    J Med Ethics; 2004 Feb; 30(1):44-9; discussion 50-2. PubMed ID: 14872072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: Science scandal or ethics scandal? Olivieri redux.
    Schafer A
    Bioethics; 2007 Feb; 21(2):111-5. PubMed ID: 17845495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic freedom in clinical research.
    Nathan DG; Weatherall DJ
    N Engl J Med; 2002 Oct; 347(17):1368-71. PubMed ID: 12397199
    [No Abstract]   [Full Text] [Related]  

  • 10. Independent review adds to controversy at Sick Kids.
    Shuchman M
    CMAJ; 1999 Feb; 160(3):386-8. PubMed ID: 10065085
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversial HSC clinical trials report made public. Hospital for Sick Children.
    Birmingham K
    Nat Med; 1999 Jan; 5(1):7. PubMed ID: 9883822
    [No Abstract]   [Full Text] [Related]  

  • 12. Constraints of interest: lessons at the Hospital for Sick Children.
    Phillips RA; Hoey J
    CMAJ; 1998 Oct; 159(8):955-7. PubMed ID: 9834722
    [No Abstract]   [Full Text] [Related]  

  • 13. Legal issues surrounding privately funded research cause furore in Toronto.
    Shuchman M
    CMAJ; 1998 Oct; 159(8):983-6. PubMed ID: 9834727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian whistleblower row prompts broader code of conduct.
    Spurgeon D
    Nature; 1998 Dec 24-31; 396(6713):715. PubMed ID: 9874365
    [No Abstract]   [Full Text] [Related]  

  • 15. Dances with the pharmaceutical industry.
    Gibson E; Baylis F; Lewis S
    CMAJ; 2002 Feb; 166(4):448-50. PubMed ID: 11873922
    [No Abstract]   [Full Text] [Related]  

  • 16. Olivieri to testify against Apotex in Europe.
    Bonetta L
    Nat Med; 2001 Jun; 7(6):644. PubMed ID: 11385480
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron chelation with oral deferiprone in patients with thalassemia.
    Wonke B; Telfer P; Hoffbrand AV
    N Engl J Med; 1998 Dec; 339(23):1712; author reply 1713-4. PubMed ID: 9867540
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron chelation with oral deferiprone in patients with thalassemia.
    Stella M; Pinzello G; Maggio A
    N Engl J Med; 1998 Dec; 339(23):1712; author reply 1713-4. PubMed ID: 9867539
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral deferiprone--controversies on its efficacy and safety.
    Choudhry VP
    Indian J Pediatr; 1998; 65(6):825-8. PubMed ID: 10773946
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients' health or company profits? The commercialisation of academic research.
    Olivieri NF
    Sci Eng Ethics; 2003 Jan; 9(1):29-41. PubMed ID: 12645227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.